Flawed ACA launch doesn’t change Rx’s mission
The halting performance of the federal health insurance exchange during its first weeks of operation dealt a harsh blow to everyone with a stake in the success of the Affordable Care Act.
The halting performance of the federal health insurance exchange during its first weeks of operation dealt a harsh blow to everyone with a stake in the success of the Affordable Care Act.
Not often does change disrupt the orderly nature of things in chain drug retailing to the degree that the recent personnel shifts at Walgreens have altered both the personnel roster at that drug chain and the priorities of the many constituencies with which the retailer interacts.
Recent events illustrate the high stakes involved in getting health care right.
Many retailers today are immersed in building multichannel capabilities. The multichannel wave has led to many good initiatives, making it easier for customers to interact with retailers across distinct channels, including fast-growing mobile channels. For example, A.T.
The announcement last month that Walgreens had agreed to acquire Kerr Drug, the 76-store, Raleigh, N.C.-based drug chain, disrupted chain drug retailing as few previous acquisitions had done. It wasn’t the size of the deal that caused such a stir.
New research that examines customer satisfaction with pharmacy operators contains some revealing insights. The studies, conducted separately by J.D. Power and Market Force Information, identify favorites among consumers and point to broader industrywide trends.
It is becoming increasingly difficult not to think of Rite Aid as one of the chain drug industry’s trendsetters.
Kerr Drug’s decision to sell its retail and specialty pharmacy businesses is another milestone on the road to consolidation that community pharmacy has been on for more than two decades.
The retail consumer shift toward wellness is well under way. Hamacher Resource Group and several leading trade associations spotted this emerging trend years ago and changed the term “health and beauty care” (HBC) to “health, beauty, and wellness” (HBW) in everything they produced.
and sell — more goods made in America, at the expense of foreign-produced products. Some 1,500 people attended the two-day summit.
The drive toward coordinated health care is redefining the relationships between providers and creating opportunities for drug chains and other community pharmacy operators to become more tightly woven into the continuum of care.
America is a nation in pain. Over 100 million Americans suffer from chronic pain, and the annual cost of health care for pain (including disability days and lost wages and productivity) is estimated at between $560 billion and $635 billion.
Loblaw Cos.’ pending acquisition of Canada’s Shoppers Drug Mart drug chain is but the latest example of a global chain drug store business that continues to pursue realignment, if not consolidation. At first glance, the Loblaws-Shoppers tie-up makes little sense.
The run-up to the launch of the centerpiece of the nation’s health care reform plan isn’t going smoothly.
Offering fast-moving consumer goods such as cold beverages, magazines, candy, gum and mints at checkout is the tried-and-true formula for ensuring quick turns on low-margin items with high consumer demand.
Unlike traditional skin care products, which are typically used for moisturizing, medicated skin care products provide relief from such conditions as acne, eczema, rashes and itching, rosacea, warts, and psoriasis.